Position in ANIX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$40,933
+$3,216 QoQ
Shares Held
14,619
0.0% QoQ
Ownership
0.043%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#30
of 62 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ANIX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026World Investment Advisors holds $5,381,853 across 15 Biotechnology names. ANIX ranks #13 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GERN |
Geron Corp
|
1,033,779 | $1,323,237 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,866 | $926,898 | |
| 3 | RPRX |
Royalty Pharma plc
|
10,301 | $577,577 | |
| 4 | MRNA |
Moderna, Inc.
|
6,784 | $475,083 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
737 | $459,548 | |
| 6 | INCY |
Incyte Corp
|
3,471 | $393,472 | |
| 7 | SLS |
SELLAS Life Sciences Group, Inc.
|
24,616 | $363,332 | |
| 8 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
4,010 | $326,855 |
All Filings in ANIX
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $40,933 | 14,619 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $37,717 | 14,619 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $45,611 | 14,619 | Shares | Sole | 2026-03-13 | |
| 2025-09-30 | $48,242 | 14,619 | Shares | Sole | 2025-10-15 | |
| No filing history on record for this holder in this stock. | ||||||